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ABSTRACT		
	
Angiopoietin-like	 8	 (Angptl8)	 inhibits	 lipolysis	 in	 the	 circulation	 together	with	
Angplt3	and	controls	post-prandial	fat	storage	in	white	adipose	tissue	(WAT).	It	
is	strongly	induced	by	insulin	in	vivo	in	WAT	and	in	vitro	in	adipocytes.		
	 In	 this	 study	we	 	addressed	 the	 function	of	Angptl8	 in	adipocytes	by	 its	
stable	 lentivirus-mediated	knock-down	in	3T3-L1	cells,	 followed	by	analyses	of	
triglyceride	 (TG)	 storage,	 lipid	 droplet	 (LD)	morphology,	 the	 cellular	 lipidome,	
lipolysis,	and	gene	expression.	
	 Depletion	 of	 Angptl8	 did	 not	 drastically	 affect	 the	 adipocytic	
differentiation	of	3T3-L1	cells	but	resulted	in	a	moderate	(18-19%)	reduction	of	
stored	 TGs.	 The	 lipidome	 analysis	 revealed	 a	 reduction	 of	 alkyl-	
phosphatidylcholines	 (PCs)	 and	 phosphatidylethanolamine	 (PE)	 plasmalogens,	
as	 well	 as	 saturated	 PCs	 and	 PEs.	 Importantly,	 the	 Angptl8	 depleted	 cells	
displayed	enhanced	lipolysis	as	measured	by	release	of	non-esterified	fatty	acids	
(NEFAs).	 Consistently,	 mRNAs	 encoding	 Angptl4	 and	 Leptin,	 which	 facilitate	
lipolysis,	 as	 well	 as	 Cpt1a,	 Cpt1b,	 and	 Pgc-1a	 involved	 in	 FA	 oxidation,	 were	
elevated.	The	Angptl8	mRNA	itself	was	suppressed	by	pharmacologic	treatments	
inducing	 lipolysis:	 stimulation	 with	 the	 b-adrenergic	 agonist	 isoproterenol	 or	
with	the	adenylate	cyclase	activator	forskolin.	
	 To	 conclude,	 knock-down	 of	 Angptl8	 in	 adipocytes	 suggests	 that	 the	
protein	 acts	 to	 inhibit	 intracellular	 lipolysis,	 analogous	 to	 its	 activity	 in	 the	
circulation.	 Depletion	 of	 Angptl8	 results	 in	 an	 altered	 cellular	 phospholipid	
composition.	 The	 findings	 identify	 Angptl8	 as	 a	 central	 insulin-regulated	
controller	of	adipocyte	lipid	metabolism.				
	
Abbreviations	 used:	 Angptl8,	 angiopoietin-like	 8;	 FA,	 fatty	 acid;	 LD,	 lipid	
droplet;	 LPL,	 lipoprotein	 lipase;	 NEFA,	 non-esterified	 FA;	 PC,	
phosphatidylcholine;	PE,	phosphatidylethanolamine;	qPCR,	quantitative	reverse	
transcriptase	 PCR;	 shRNA,	 short	 hairpin	 RNA;	 TG,	 triglyceride;	 WAT,	 white	
adipose	tissue		
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1.	Introduction	
	
Angiopoietin-like	8	(Angptl8)	 is	a	protein	predominantly	expressed	 in	 the	 liver	
and	 adipocytes	 (Quagliarini	 et	 al.,	 2012).	 It	 inhibits	 lipoprotein	 lipase	 (LPL)	
activity	in	plasma	similar	to	Angptls	3	and	4	(Dijk	and	Kersten,	2016;	Quagliarini	
et	al.,	2012;	Santulli,	2014;	Wang	et	al.,	2013)	and	is	suggested	to	act	in	concert	
with	 Angptl3	 in	 the	 circulation	 (Quagliarini	 et	 al.,	 2012).	 Consistently,	 hepatic	
overexpression	 of	 Angptl8	 resulted	 in	 elevated	 plasma	 triglycerides	 (TGs)	 in	
mice	 (Dang	 et	 al.,	 2016;	Quagliarini	 et	 al.,	 2012;	Wang	 et	 al.,	 2013).	 Angptl8	is	
markedly	 induced	upon	 insulin	stimulation	 in	both	hepatocytes	and	adipocytes	
(Nidhina	 Haridas	 et	 al.,	 2015;	 Ren	 et	 al.,	 2012).	 Overexpression	 of	 Angptl8	 in	
hepatocytes	was	 reported	 to	 enhance	 insulin	 signaling	 via	 the	 Akt-GSK3β	 and	
Akt-FoxO1	pathways	(Rong	Guo	et	al.,	2016).	Characterization	of	Angptl8	knock-
out	 mice	 provided	 evidence	 for	 an	 important	 role	 of	 the	 protein	 in	 the	 post-
prandial	distribution	of	FAs	between	storage	in	WAT	and	tissues	which	oxidize	
them	(Wang	et	al.,	2013).		
	
Most	of	 the	recent	studies	suggest	 that	plasma	ANGPTL8	 levels	are	elevated	 in	
type	2	diabetes	(T2D),	insulin	resistance	or	obesity	(Abu-Farha	et	al.,	2016;	Chen	
et	al.,	2015;	Fu	et	al.,	2014).	However,	ANGPTL8	was	 found	 to	be	 the	 the	most	
strongly	insulin-induced	individual	gene	in	human	WAT	in	vivo	(Nidhina	Haridas	
et	al.,	2015;	Soronen	et	al.,	2012),	suggesting	that,	apart	from	its	function	in	the	
circulation,	it	may	also	execute	an	unknown	intracellular	function	in	adipocytes.	
Since	 adipocytes	 do	 not	 express	 Angptl3,	 a	 functional	 partner	 of	 Angptl8	
(Conklin	 et	 al.,	 1999;	Quagliarini	 et	 al.,	 2012),	 it	 is	 likely	 that	 the	 latter	 has	 an	
independent	role	in	this	cell	type.	Indeed,	an	RNA	interference	study	in	cultured	
adipocytes	 suggested	 that	 the	 protein	 promotes	 adipocyte	 differentiation	 and	
lipid	 storage	 (Ren	 et	 al.,	 2012).	 Interestingly,	 exogenous	 recombinant	 Angptl8	
was	 shown	 to	 downregulate	 the	 expression	 of	 adipocyte	 triglyceride	 lipase	
(ATGL)	 in	 both	 hepatocytes	 and	 adipocytes	 (Zhang	 et	 al.,	 2016).	 In	 contrast,	
circulating	 Angptl8	 	was	 reported	 to	 enhance	 ATGL	 expression	 in	 the	WAT	 of	
mice	(Dang	et	al.,	2016).	To	conclude,	the	function	of	Angptl8	in	adipocyte	lipid	
metabolism	is	poorly	understood	and	thus	warrants	detailed	study.	
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In	this	study,	the	role	of	Angptl8	in	controlling	adipocyte	TG	content	and	lipolysis	
was	 analyzed	 by	 means	 of	 its	 shRNA	 lentivirus-mediated	 knock-down	 in	 the	
3T3-L1	adipocyte	model.	Lipid	droplet	morphology	was	monitored,	the	lipidome	
of	 Angptl8	 knock-down	 and	 control	 cells	 was	 analyzed,	 and	 the	 expression	 of	
relevant	genes	quantified.		
	
	
2.	Materials	and	methods	
	
2.1.	Cell	culture	and	RNA	interference	
	
3T3-L1	 fibroblasts	 were	 grown	 in	 high	 glucose	 Dulbecco’s	 Modified	 Eagle	
Medium	 (DMEM,	 Sigma-6429,	 Sigma-Aldrich,	 St.	 Louis,	 MO)	 with	 10%	 fetal	
bovine	 serum	 (FBS).	 	 At	 70%	 confluency	 	 cells	 were	 infected	 	 with	 	 lentiviral	
particles	 expressing	 shRNA	 targeting	 Angptl8,	 Clone1:	
AAGCCCACCAAGAATTTGAGA,	 Clone2:	 TATGACAGAGCACTGGAATTC	 (CSTVRS-
MissionTM,	 Sigma-Aldrich)	 and	 the	 transduced	 cell	 pools	were	 selected	 using	 3	
μg/ml	 of	 puromycin.	 The	 selected	 3T3-L1	 cells	 were	 further	 expanded	 and	
differentiated.	 Cells	 were	 grown	 till	 confluency	 and	 differentiated	 as	 follows:	
Cells	 were	 treated	 with	 500	 μM	 3-isobutyl-1-methylxanthine-IBMX,	 250	 nM	
dexamethasone,	100	nM	insulin	and	2	μM	rosiglitazone	in	complete	medium	for	
the	 first	 48	 h,	 followed	by	 100	nM	 insulin	 and	2	 μM	 rosiglitazone	 in	 complete	
medium	for	the	next	48	hours.	Fresh	complete	medium	was	then	changed	every	
48	 h	 till	 day	 6-8.	 The	 experiments	 were	 carried	 out	 when	 the	 cells	 were	
completely	 differentiated	 as	 judged	 from	 the	 abundant	 presence	 of	 large	
cytoplasmic	lipid	droplets.	
	
2.2.	Quantitative	reverse	transcriptase	PCR	(qPCR)	
	
Total	RNA	 from	3T3-L1	control	and	Angptl8	knock-down	adipocytes	 	 cells	was	
isolated	using	the	PureLink®	RNA	Mini	(Ambion/Thermo	Fisher,	Waltham,	MA)	
or	 the	 QIAGEN	 (Germantown,	 MD)	 RNeasy	 Mini	 Kit	 (Cat	 No./ID:	74104).	 For	
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Lipolysis	 related	 genes	 both	 control	 and	 silenced	 cells	 were	 treated	 with	
isoproterenol	(10	μM)	for	2	hours.	cDNA	was	prepared	using	the	VILO®	reverse	
transcriptase	 kit	 (Invitrogen,	 Carlsbad,	 CA).	Real	 time	quantitative	PCR	 (qPCR)	
was	 carried	 out	 in	 Light	 Cycler	 480	 II	 (Roche	 Applied	 Science,	 Penzberg,	
Germany)	 using	 Roche	 SYBR-Green®	 master	 mix	 and	 gene-specific	 primers	
(Table	 1).	 The	 data	 were	 normalized	 to	 the	 expression	 of	 two	 housekeeping	
genes,	 Succinate	 dehydrogenase	 complex,	 subunit	 A	 (SDHA)	 and	 the	 acidic	
ribosomal	phosphoprotein	36B4.		
	
2.3.	Triglyceride	analysis	
	
Total	 lipids	 were	 isolated	 from	 3T3-L1	 control	 and	 Angptl8	 knock-down	
adipocytes	using	the	Bligh	and	Dyer	method	and	the	extracts,	together	with	TG	
standards,	 were	 separated	 by	 automatic	 thin	 layer	 chromatography	 (Camag,	
Berlin,	 Germany)	 by	 using	 hexane/diethyl	 ether/acetic	 acid	 (80:20:1)	 as	 the	
solvent	 system.	 The	 plates	 were	 stained	 with	 8%	 H3PO4	 (aq)	 and	 3%	 cupric	
sulfate	(aq)	and	heated	at	180°C.	The	TG	standards	and	the	corresponding	bands	
in	 control	 and	 knock-down	 cells	 were	 quantified	 using	 Image	 J	 software,	
followed	by	normalization	for	total	cell	protein.	
	
2.4.	Lipolysis	assay	
	
Non-esterified	 fatty	 acid	 (NEFA)	 release	 from	 3T3-L1	 control	 and	 Angptl8	
silenced	 adipocytes	 were	 measured	 under	 basal	 and	 isoproterenol	 (10	 μM)	
treated	 conditions	 after	 a	 2-hour	 incubation.	 Cell	 supernatants	 were	 collected	
and	NEFA	release	quantified	using	HR	Series	NEFA-HR(2)	kit	(Wako	Diagnostics, 
Richmond,	VA)	according	to	the	manufacturer’s	protocol.	
	
2.5.	Lipidome	analysis	
	
Lipids	were	 quantified	 by	 direct	 flow	 injection	 electrospray	 ionization	 tandem	
mass	spectrometry	(ESI-MS/MS)	in	positive	ion	mode	using	the	analytical	setup	
and	 strategy	 described	 previously	 (Liebisch	 et	 al.,	 2004).	 A	 precursor	 ion	 of	
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m/z	184	 was	 used	 for	 PC,	 sphingomyelin	 (SM)	 (Liebisch	 et	 al.,	 2004)	 and	
lysophosphatidylcholine	 (LPC)	 (Liebisch	 et	 al.,	 2002).	 The	 following	 neutral	
losses	were	applied:	PE	141,	phosphatidylserine	(PS)	185,	phosphatidylglycerol	
(PG)	189	and	phosphatidylinositol	(PI)	277	(Brugger	et	al.,	1997;	Matyash	et	al.,	
2008).	PE-based	plasmalogens	(PE	P)	were	analyzed	according	to	the	principles	
described	 in	 (Zemski	 Berry	 and	Murphy,	 2004).	 Lipid	 species	were	 annotated	
according	 to	 the	 recently	 published	 proposal	 for	 shorthand	 notation	 of	 lipid	
structures	 that	 are	 derived	 from	 mass	 spectrometry	 (Liebisch	 et	 al.,	 2013).	
Glycerophospholipid	 species	 annotation	was	 based	 on	 the	 assumption	 of	 even	
numbered	carbon	chains	only.		
	
2.6.	Staining	of	lipid	droplets	
	
3T3-L1	control	and	Angptl8	knock-down	adipocytes	were	washed	and	fixed	with	
4%	paraformaldehyde.		Cells	were	then	permeabilised	with	0.1%	Triton	x-100	in	
Phosphate-buffered	 saline,	 washed	 and	 then	 stained	 with	 100	 nM	 Bodipy®	
493/503	(Molecular	Probes/Life	Technologies,	Eugene,	OR)	for	one	hour.	Nuclei	
were	 stained	 with	 DAPI.	 Cells	 were	 imaged	 using	 Zeiss	 Axio	 Observer	 Z1	
microscope	 (Carl	 Zeiss	 Imaging	 Solutions	 GmbH,	 Oberkochen,	 Germany)	
equipped	with	Colibri	laser.		
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3.	Results	
	
3.1.	Stable	knock-down	of	Angptl8	in	3T3-L1	adipocytes	reduces	the	cellular	TGs	
	
To	 elucidate	 the	 functional	 role	 of	 Angptl8	 in	 adipocyte	 lipid	 metabolism,	 we	
generated	stably	transduced	3T3-L1	adipocyte	pools	by	using	two	independent	
shRNAs	targeting	the	mRNA,	designated	Angptl8	KD1	and	KD2.	The	knock-down	
efficiency	was	 evaluated	by	 qPCR,	 revealing	 an	 approximately	 similar,	 70-75%	
reduction	of	the	Angptl8	message	for	KD1	and	KD2	(Fig.	1A).	Analysis	of	the	TG	
content	 of	 the	 transduced	 KD	 adipocyte	 pools	 by	 thin-layer	 chromatography	
(TLC),	by	normalizing	the	TGs	for	total	cell	protein,	revealed	a	18-19%	reduction	
in	the	Angptl8	KD	cells	as	compared	to	controls	transduced	with	a	non-targeting	
shRNA	lentivirus	(Fig.	1B).	However,	no	reduction	in	the	mRNAs	encoding	the	TG	
synthesizing	 enzymes	 (Monoacylglycerol	 O-Acyltransferase	 1-MOGAT1,	
Glycerol-3-phosphate	 acyltransferase-GPAT1,	 Diacylglycerol	 O-Acyltransferase-
DGAT1)	was	observed	(data	not	shown).	Upon	fluorescence	microscopy	imaging	
of	 the	 lipid	 droplets	 (LD)	 stained	 by	 using	 the	 Bodipy	 493/503	 dye,	 the	
accumulation	of	 large	LDs	 in	all	 cell	pools,	 the	non-targeting	controls,	KD1	and	
KD2,	 was	 evident	 (Fig.	 1C,	 E).	 While	 the	 control	 and	 KD2	 cells	 appeared	
indistinguishable	from	each	other,	the	distribution	of	LD	and	cell	size	in	the	KD1	
cell	 pool	 was	 more	 heterogeneous,	 being	 characterized	 by	 a	 large	 number	 of	
relatively	 small	 LDs	 in	 some	cells	 and	only	 few	very	 large	ones	 in	others.	 (Fig.	
1D).					
	
3.2.	 Knock-down	 of	 Angptl8	 reduces	 ether	 phospholipids	 as	 well	 as	 saturated	
PCs	and	PEs		
	
To	 obtain	 an	 overview	 of	 the	 effects	 of	 Angptl8	 reduction	 on	 the	 cellular	
lipidome,	we	subjected	the	extracted	total	cell	 lipids	 to	quantitative	direct	 flow	
injection	 electrospray	 ionization	 tandem	 mass	 spectrometry	 (ESI-MS/MS)	
analysis.	 The	 data	 obtained	 for	 the	 Angptl8	 KD1	 and	 KD2	 were	 individually	
compared	 to	 the	 non-targeting	 shRNA	 controls.	 While	 there	 was	 quite	
considerable	variation	between	many	individual	lipid	molecular	species	between	
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the	 KD1	 and	 KD2	 cell	 pools,	 a	 number	 of	 consistent	 alterations	 in	 the	 lipid	
classes	were	observed.	The	major	finding	was	a	reduction	of	ether	phospholipids	
(alkyl-PCs	 and	 PE	 plasmalogens)	 in	 the	 KD	 cell	 pools	 (Fig.	 2A-E).	 In	 addition,	
saturated	PCs,	lysoPCs	and	PEs,	which	however	are	very	low	abundancy	species,	
were	significantly	reduced	in	both	Angptl8	KD	pools	(Fig.	2F-H).	
	
3.3.	Angptl8	knock-down	enhances	lipolysis	in	3T3-L1	adipocytes	
	
Since	 we	 saw	 in	 the	 Angptl8	 KD	 adipocytes	 a	 reduction	 of	 stored	 TGs	 and	
because	 Angptl8	 together	 with	 Angptl3	 inhibits	 LPL	 activity	 in	 the	 circulation	
(Quagliarini	 et	 al.,	 2012;	 Wang	 et	 al.,	 2013),	 we	 decided	 to	 measure	 the	
intracellular	 lipolysis	 in	 the	Angptl8	 and	 control	 adipocytes	 in	 the	presence	or	
absence	 of	 b-adrenergic	 (isoproterenol)	 stimulation.	 Measurement	 of	 NEFA	
released	into	the	culture	medium	revealed	a	significant	enhancement	of	lipolysis	
in	 both	KD1	 and	KD2	 cell	 pools	 as	 compared	 to	 the	 non-targeting	 control,	 the	
volume	 of	 the	 effect	 being	 more	 pronounced	 for	 KD1.	 This	 enhancement	 of	
lipolysis	 was	 evident	 under	 both	 the	 unstimulated	 and	 the	 isoproterenol-
stimulated	conditions	(Fig.	3A).	The	Angptl8	mRNA	in	naive	3T3-L1	adipocytes	
was	 significantly	 suppressed	 by	 both	 isoproterenol	 and	 forskolin,	 which	
stimulates	adenylate	cyclase	resulting	in	enhanced	protein	kinase	A	activity	and	
lipolysis	 (Fig.	 3B).	 Together,	 these	 data	 suggest	 that	 the	 endogenous	 Angptl8	
inhibits	 adipocyte	 lipolysis,	 and	 pharmacologic	 stimulation	 of	 lipolysis	 down-
regulates	the	expression	of	Angptl8.		
	
3.4.	 Effects	 of	 Angptl8	 knock-down	 on	 the	 expression	 of	 genes	 controlling	
lipolysis	and	lipid	oxidation	
	
Prompted	 by	 the	 observed	 enhancement	 of	 lipolysis	 in	 the	 Angptl8	 KD	
adipocytes,	 we	 analyzed	 mRNA	 expression	 of	 key	 genes	 involved	 in	 lipolysis.	
After	 2-h	 isoproterenol	 treatment	 (induction	of	 lipolysis)	 the	mRNAs	 encoding	
Angptl4,	 Pnpla3,	 Pnpla2/adipose	 triglyceride	 lipase	 (ATGL),	 and	 hormone-
sensitive	 lipase	 (HSL)	 were	 quantified.	 In	 the	 both	 Angtpl8	 KD	 cell	 pools,	 the	
Angptl4	message	was	 significantly	 increased	 as	 compared	 to	 the	non-targeting	
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control,	 while	 the	 Pnpla2/ATGL	 and	 HSL	 mRNAs	 remained	 unchanged.	
Moreover,	 there	 was	 a	 marked	 increase	 of	 the	 Pnpla3	message	 in	 KD1	which	
was,	however,	not	observed	in	the	KD2	cells	(Fig.	4A).		
	 We	 next	 analyzed	 genes	 associated	 with	 FA	 oxidation,	 PGC-1a,	 Cpt1a,	
Cpt1b,	 and	Ucp1.	 The	 Cpt1a	 and	 Cpt1b	mRNAs	were	 significantly	 increased	 in	
both	 Angptl8	 KD	 cell	 pools,	 while	 PGC-1a	 was	 elevated	 in	 KD1	 and	 showed	 a	
similar	trend	in	KD2	(Fig.	4B).	We	also	analyzed	the	expression	of	the	adipokine	
Leptin,	which	is	known	to	play	a	role	in	adipocyte	lipolysis	in	addition	to	its	role	
as	 a	 satiety	 signal	 (Flak	 and	Myers,	 2016;	Kim	 et	 al.,	 2008).	 The	 Leptin	mRNA	
was	remarkably	induced	in	the	Angptl8	KD	adipocytes	(Fig.	4B).	
	
	
4.	Discussion	
	
In	the	present	study,	we	employed	the	3T3-L1	adipocyte	model	to	investigate	the	
functional	 effects	of	Angptl8	knock-down	via	 stable	 lentivirus-mediated	 shRNA	
expression.	 Depletion	 of	 Angptl8	 did	 not	 drastically	 affect	 the	 adipocytic	
differentiation	 of	 the	 cells	 but	 resulted	 in	 a	 moderate	 (18-19%)	 reduction	 of	
stored	 TGs.	 Lipidome	 analysis	 revealed	 a	 reduction	 of	 ether	 phospholipids.	
Importantly,	 the	 Angptl8	 depleted	 cells	 displayed	 enhanced	 lipolysis	 as	
measured	 by	 the	 release	 of	 NEFAs,	 and	 treatments	with	 the	 lipolysis-inducing	
agents	 isoproterenol	 or	 forskolin	 suppressed	 the	 Angptl8	 mRNA.	 Increased	
expression	 of	 mRNAs	 encoding	 Cpt1a,	 Cpt1b,	 and	 PGC-1a	 involved	 in	 FA	
oxidation,	as	well	as	Leptin,	was	observed	in	the	Angptl8	KD	adipocytes.	 	
	 We	 observed	 in	 the	 Angptl8	 KD	 adipocytes	 a	 moderate	 but	 consistent	
reduction	 of	 stored	 TGs.	 Several	 studies	 have	 documented	 an	 induction	 of	 the	
Angptl8	message	during	adipocyte	differentiation	(Ebert	et	al.,	2014;	Ren	et	al.,	
2012)	and	by	their	 treatment	with	 insulin,	which	 favours	 the	storage	of	FAs	as	
TGs	 (Ebert	 et	 al.,	 2014;	 Nidhina	 Haridas	 et	 al.,	 2015;	 Ren	 et	 al.,	 2012).	 In	 a	
previous	 study,	Ren	 et	 al.	 (2012)	 carried	 out	 transient	 siRNA-mediated	 knock-
down	of	Angptl8	 in	 the	3T3-L1	adipocyte	model	and	observed	a	defect	 in	 their	
adipocytic	differentiation.	We	observed	 in	 the	 stable	knock-down	cell	pools	no	
drastic	defect	 in	adipogenesis;	However,	 the	moderate	 reduction	of	 stored	TGs	
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we	 detected	 could	 reflect	 a	 mild	 defect	 in	 the	 terminal	 stages	 of	 adipocytic	
differentiation.		 	
	 The	 present	 lipidome	 analyses	 revealed	 a	 significant	 reduction	 of	 alkyl-
PCs	 and	 PE	 plasmalogens	 with	 an	 ether-linked	 FA	 chain,	 usually	 in	 the	 sn-1	
position.	 Synthesis	 of	 ether	 phospholipids	 begins	 by	 peroxisomal	 enzyme	
machineries	(Braverman	and	Moser,	2012).	We	therefore	considered	it	possible	
that	 Angptl8	 depletion	 could	 result	 in	 a	 peroxisomal	 dysfunction.	 Synthesis	 of	
alkyl-glycerol	 ether	 lipids	 or	 exogenous	 treatment	 with	 these	 lipids	 promote	
adipocytic	 differentiation	 (Homan	 et	 al.,	 2011).	 Consistently,	 Pex7	 KO	 mice,	
which	 lack	 plasmalogens,	 have	 reduced	 body	 fat	 and	 display	 an	 abnormal	
morphology	of	both	white	and	brown	fat,	characterized	by	small	LD	(Brites	et	al.,	
2011).	 Besides	 the	 defect	 in	 ether	 phospholipids,	 we	 observed	 a	 reduction	 of	
saturated	 PCs	 and	 PEs,	 which,	 however,	 are	 very	 minor	 species.	 Since	 no	
significant	change	was	observed	in	the	total	saturation	degree	of	phospholipids	
(data	 not	 shown),	 the	 reason	 for	 this	 observation	 remains	 unknown.	
Nevertheless,	 we	 find	 it	 possible	 that	 the	 observed	 depletion	 of	 ether	
phospholipids,	 which	 usually	 have	 a	 polyunsaturated	 FA	 chain	 in	 the	 sn-2	
position,	 might	 decrease	 the	 fluidity	 of	 cellular	 membranes	 (Pietiläinen	 et	 al.,	
2011;	 Saitoh	 et	 al.,	 2009),	 and	 the	 reduction	 of	 saturated	 PCs	 and	 PEs	 could	
represent	a	compensatory	response	aimed	at	resisting	the	fluidity	change.	
	 A	 major	 functional	 effect	 of	 Angptl8	 depletion	 was	 an	 enhancement	 of	
lipolysis	 within	 adipocytes,	 suggesting	 that	 the	 endogenous	 Angptl8	 acts	 to	
inhibit	 lipolysis.	 This	 would	 be	 fully	 consistent	 with	 its	 robust	 induction	 by	
insulin	 in	 WAT	 (Nidhina	 Haridas	 et	 al.,	 2015;	 Soronen	 et	 al.,	 2012).	 Under	
circumstances	 favouring	 FA	 deposition	 as	 TGs	 in	 WAT,	 it	 is	 plausible	 that	
hydrolysis	of	the	stored	TGs	should	simultaneously	be	suppressed.	It	thus	seems	
that,	 analogous	 to	 the	 activity	 of	 Angptl8	 as	 an	 inhibitor	 of	 lipolysis	 in	 the	
circulation	(Quagliarini	et	al.,	2012;	Wang	et	al.,	2013),	it	could	execute	a	similar	
function	intracellularly.	 	We	failed	to	detect	changes	in	the	mRNA	expression	of	
central	 mediators	 of	 lipolysis,	 ATGL	 and	 HSL,	 while	 a	 small	 increase	 of	 the	
Angptl4	message	was	evident;	Angptl4	acts	as	 stimulator	of	adipocyte	 lipolysis	
(Gray	et	al.,	2012),	so	its	induction	could	contribute	to	the	observed	increase	of	
lipolysis.	 In	KD1	cells,	which	displayed	a	more	potent	enhancement	of	 lipolysis	
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than	KD2,	also	a	significant	increase	of	the	Pnpla3	mRNA	was	observed;	Of	note,	
Pnpla3	 is	known	to	enhance	 lipolysis	and	TG	remodeling	 in	hepatocytes	(He	et	
al.,	2010;	Ruhanen	et	al.,	2014).	Its	elevated	expression	could	thus	facilitate	the	
potent	increase	of	lipolysis	in	KD1.	At	present	we	do	not	know	the	reason	for	this	
discrepancy	between	KD1	and	KD2.	However,	we	find	it	possible	that	an	shRNA	
off-target	effect	in	KD2	could	alleviate	the	lipolysis	phenotype.	Plasmalogens	act	
as	 a	 source	 of	 prostaglandin	 E2	 (PGE2),	 which	 inhibits	 lipolysis	 in	 adipocytes	
(Chatzipanteli	 et	 al.,	 1992;	 Fain	 et	 al.,	 2000).	 Reduction	 of	 PGE2	 increases	 the	
cellular	 cAMP,	 resulting	 in	 enhanced	 lipolysis	 (Jaworski	 et	 al.,	 2009).	
Consistently,	patients	with	the	Zellweger	syndrome,	a	genetic	peroxisome	defect,	
display	 a	 deficiency	 in	 plasmalogens;	 Their	 fibroblasts	 contain	 an	 increased	
number	 of	 b-adrenergic	 receptors	 and	 are	 therefore	 more	 responsive	 to	
isoproterenol-induced	cAMP	responses	(Tiffany	et	al.,	1990).		
	 Interestingly,	we	observed	a	robust	induction	of	the	Leptin	mRNA	in	the	
Angptl	 KD	 cells	 under	 the	 basal	 culture	 conditions,	 but	 the	mRNA	was	 hardly	
detectable	under	the	lipolytic	conditions	employed.	This	finding	is	controversial	
since	PGE2	is	known	to	enhance	leptin	secretion	by	adipocytes	(Fain	et	al.,	2000;	
Harris,	2014).	Thus,	 the	observed	 induction	of	Leptin	mRNA	could	 represent	a	
compensatory	 response	 to	 reduced	 synthesis	 of	 PGE2,	 or	 depletion	 of	 Angptl8	
might	 affect	Leptin	expression	 through	another,	 thus	 far	unknown	mechanism.	
In	addition	 to	 the	above	 lipolysis	phenotype,	we	also	 found	a	number	of	genes	
associated	with	FA	oxidation	significantly	elevated	in	the	Angptl8	KD	cells.	This	
is	consistent	with	the	observed	increase	of	lipolysis	releasing	free	FAs,	which	can	
be	 used	 as	 an	 energy	 source	 via	 oxidation,	 and	 on	 the	 other	 hand,	 need	 to	 be	
degraded	to	reduce	FFA-mediated	toxicity	to	cells	(Saha	et	al.,	2004).	 	 		
	 To	 conclude,	 knock-down	 of	 Angptl8	 in	 adipocytes	 suggests	 that	 the	
protein	 acts	 to	 inhibit	 intracellular	 lipolysis.	 Modulation	 of	 the	 cellular	 ether	
phospholipid	 content	may	 be	 one	 of	 the	 underlying	mechanisms.	 The	 findings	
identify	 Angptl8	 as	 a	 central	 insulin-regulated	 controller	 of	 adipocyte	 lipid	
storage	and	metabolism.				
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Table	1.	The	primers	employed	for	qPCR	analyses	
	
Genes Primer sequence 
ANGPTL8 (Forward) F= ccctcaatggcgtgtacaga 
(Reverse) R= ccacctgaatctccgacagg 
 
ANGPTL4 F= caaaacagcaagatccagca 
R=ttggaagagttcctggcagt 
 
ATGL F= caacgccactcacatctacgg 
R= ggacacctcaataatgttggcac 
 
PNPLA3 F= attcccctcttctctggccta 
R= atgtcatgctcaccgtagaaa 
 
HSL F=caacggataccgtagtttggtg 
R=cgggatttgtgtagtaggtgtg 
 
PGC1-a F=tgctagcggttctcacagag 
R=agtgctaagaccgctgcatt 
 
CPT1a F= tggcatcatcactggtgtgtt 
R= gtctagggtccgattgatctttg 
 
CPT1b F= tacaacaggtggtttgaca 
R=gtctagggtccgattgatctttg 
 
UCP1 F=aggcttccagtaccattaggt 
R=ctgagtgaggcaaagctgattt 
 
LEPTIN F= tgctccagcagctgcaaggtgcaag 
R=tcagcattcagggctaacatccaactgtt 
 
36B4 F= catgctcaacatctcccccttctcc 
R= gggaaggtgtaatccgtctccacag 
 
PBGD F= gtgagtgtgttgcacgatcc 
R= tgggtcatcttctggaccat 
 
MOGAT1 F= ctcgtgcaggtgtgcattg 
R= gcgttttgacaagacagattgg 
 
GPAT1 F= acagttggcacaatagacgttt 
R= ccttccatttcagtgttgcaga 
 
DGAT1 F= tccgtccagggtggtagtg 
R= tgaacaaagaatcttgcagacga 
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Figure	captions	
	
Fig.	1.	Knock-down	of	Angptl8	in	3T3-L1	adipocytes	reduces	cellular	TG	storage.	
A.	 The	 degree	 of	 Angptl8	 knock-down	 in	 cell	 pools	 genarated	 by	 using	 two	
independent	 shRNA	 lentiviruses	 was	 evaluated	 by	 qPCR	 B.	 The	 cellular	 TG	
content	normalized	for	total	cell	protein	is	depicted	(n=5).	In	A,	the	data	is	for	a	
representative	 experiment	 performed	 in	 triplicate	 (mean	 ±	 SD),	 and	 triplicate	
PCR	amplifications	for	each	specimen;	**p<0.01.	The	data	in	B	represents	mean	±	
SD;	 N=8-9	 from	 2-3	 independent	 experiments;	 **p<0.01.	 C-E.	 Fluorescence	
microscopy	of	 lipid	droplets	 in	 the	control	 (C),	KD1	(D)	and	KD2	(E)	cells.	LDs	
were	stained	with	Bodipy	493/503	(green)	and	nuclei	with	DAPI	(blue),	Bar,	100	
µm.	
	
Fig.	 2.	 The	 lipid	 classes	 significantly	 affected	 by	 Angptl8	 knock-down.	 Total	
lipids	 of	 Angptl8	 KD	 and	 control	 3T3-L1	 adipocytes	 were	 subjected	 to	
quantitative	 mass	 spectrometric	 lipidome	 analysis.	 The	 phospholipid	 classes	
consistently	affected	 in	both	KD1	and	KD2	cell	pools	are	depicted.	A.	Alkyl-PCs	
with	 an	 ether-bonded	 FA.	 Annotation	 is	 based	 on	 the	 assumption	 of	 even	
numbered	carbon	chains	only.	B.	PE-plasmalogens	(PE_P-16:0;	vinyl-ether-16:0).	
C.	PE_P-18:1.	D.	PE_P-18:0.	E.	Total	PE_Ps.	 	F.	Saturated	PCs.	G.	Saturated	 lyso-
PCs.	H.	Saturated	PEs.	The	data	represent	a	mean	±	SD,	N=6;	*p<0.05,	**p<0.01,	
***p<0.001.	
	
Fig.	3.	Depletion	of	Angptl8	enhances	adipocyte	lipolysis.	A.	Lipolysis	in	mature	
3T3-L1	 adipocytes	 was	 induced	 by	 a	 2-h	 incubation	 in	 the	 absence	 (-ISO)	 or	
presence	 (+ISO)	 of	 the	b-adrenergic	 agonist	 isoproterenol,	 and	 NEFA	 released	
into	 growth	 medium	 was	 quantified.	 The	 data	 represent	 a	 mean	 ±	 SD;	 N=4,	
*p<0.05,	**p<0.01.	B.	Naive	3T3-L1	adipocytes	were	incubated	for	24	h	with	10	
µM	 	 isoproterenol	 or	 0.2	µM	 forskolin,	 followed	 by	 qPCR	 quantification	 of	 the	
Angptl8	mRNA.	The	data	represent	a	mean	±	SD,	N=6,	***p<0.001.	
	
Fig.	 4.	 Gene	 expression	 changes	 observed	 in	 the	 Angptl8	 KD	 cell	 pools	 as	
compared	 to	 non-targeting	 (NT)	 controls:	 qPCR	 analyses.	 	 A.	 Quantities	 of	
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mRNAs	involved	in	lipolysis	(identified	on	the	right),	in	3T3-L1	adipocytes	after	
2-h	treatment	with	10	µM	isoproterenol	(+ISO).	B.	Quantities	of	mRNAs	involved	
in	FA	oxidation	and	Leptin	(identified	on	the	right)	in	3T3-L1	adipocytes	under	
the	normal	growth	conditions.	The	data	represent	a	mean	±	SD,	N=8-9,	from	2-3	
independent	 experiments;	 *p<0.05,	 **p<0.01,	 ***p<0.001.	 The	 cell	 pools	 are	
identified	 at	 the	bottom;	 the	mRNA	quantities	 are	 expressed	 in	 arbitrary	units	
(AU).	
	
		
	
	
	
